Edition:
United Kingdom

Shanghai Pharmaceuticals Holding Co Ltd (2607.HK)

2607.HK on Hong Kong Stock

20.60HKD
20 Apr 2018
Change (% chg)

HK$-0.40 (-1.90%)
Prev Close
HK$21.00
Open
HK$21.00
Day's High
HK$21.00
Day's Low
HK$20.45
Volume
5,563,718
Avg. Vol
6,836,475
52-wk High
HK$24.25
52-wk Low
HK$18.20

Select another date:

Mon, Mar 26 2018

BRIEF-Shanghai Pharmaceuticals Holding to pay cash dividend of 3.8 yuan (pre-tax) for every 10 shares

* Says it plans to pay a cash dividend of 3.8 yuan (pre-tax) for every 10 shares as the dividend payment plan for 2017

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says co's Shanghai-based wholly owned unit received goods manufacture practice (GMP) certificate from Shanghai Food and Drug Administration, for therapeutic biological products

Shanghai Pharmaceuticals plans $400 mln share sale to fund production

HONG KONG, Jan 19 Shanghai Pharmaceuticals Holding Co Ltd said on Friday it planned to sell HK$3.13 billion ($400 million) worth of new shares to fund the development of its manufacturing and distribution businesses.

BRIEF-Shanghai Pharmaceuticals Holding To Place 153.2 Mln New H Shares At HK$20.43 Per H Share​

* ‍TO PLACE 153.2 MILLION NEW H SHARES AT HK$20.43 PER H SHARE​

BRIEF-Shanghai Pharmaceuticals Holding units receive GMP certificate

* Says Changzhou-based pharmaceuticals unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration, for its products including acyclovir, ganciclovir and production line

BRIEF-Shanghai Pharmaceuticals Holding unit receives GMP certificate

* Says its unit received goods manufacture practice (GMP) certificate from Shandong Food and Drug Administration, for its products including mixture, oral liquid, drops and bulk drug

BRIEF-Shanghai Pharmaceuticals Holding Announces ‍CSRC's Approval On Issuance Of New Shares

* ANNOUNCES ‍CSRC'S APPROVAL ON ISSUANCE OF NEW 153.2 MILLION H SHARES AT VALUE OF RMB1 PER SHARE​ Source text for Eikon: Further company coverage:

BRIEF-Shanghai Pharmaceuticals Gets Regulatory Approval To Issue Up To 153.2 Mln H-Shares

* SAYS IT GETS SECURITIES REGULATOR'S APPROVAL TO ISSUE UP TO 153.2 MILLION H-SHARES Source text in Chinese: http://bit.ly/2C81gx7 Further company coverage: (Reporting by Hong Kong newsroom)

Select another date: